Bacteremia Sepsis Clinical Trial
Official title:
Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia: a Prospective, Non-interventional, Multi-centric, Clinical Performance Study
The aim of this study is to assess the sensitivity, specificity, and accuracy of the Resistell Phenotech device in testing antibiotic susceptibility of Gram-negative bacteria (i.e., E. coli or K. pneumoniae) to clinically relevant antibiotics. The study is designed as a prospective, non-interventional, multi-center, single-arm study. The blood culture samples from bacteremia patients that are positive for E. coli or K. pneumoniae will be tested with the Resistell Phenotech device after strain identification by MALDI-TOF. The results of the Resistell AST will be compared with the results from the disk diffusion tests (all sites use the Kirby-Bauer disk diffusion test), and site dependent tests (VITEK® 2, BD Phoenix™, MicroScan WalkAway system, and/or EUCAST RAST), which are currently the standard AST methods in the microbiology laboratories at the participating sites.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03611257 -
Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases
|
N/A | |
| Completed |
NCT03876990 -
Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.
|
N/A | |
| Completed |
NCT05002413 -
Nanomotion-based Resistell AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia and/or Sepsis
|
||
| Active, not recruiting |
NCT05296590 -
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
|
||
| Completed |
NCT03577366 -
Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
|
||
| Recruiting |
NCT06187168 -
Risk Factors of Post-ERCP Sepsis
|